Asclepias
Diamond Member
You sound intimidated and hate being educated. I know you were taught ignorance was bliss but it really isnt. Again I have to correct you. Even Caucasians dont all look the same and they have the smallest gene pool. Some Africans/African Americans are pretty much indistinguishable from each other. Mexicans can be Black, White, or NA looking. What you are doing is being ignorant and claiming your lack of knowledge represents the truth. I hate willful ignorance. Some people such as yourself seem to embrace it and resist truth. BTW...No I wont STFU. I will continue to cause you emotional trauma.You hate having your ignorance challenged. I understand.You do realize Puerto Ricans have a lot of African blood dont you?Hispanic is not a race either. There are millions of Black Hispanics. Latino or Hispanic is basically the same thing.
Well, I'm using it in that context to say she looks like maybe she is from Puerto Rico rather than Africa. Okay, you PITA?
Whatever.I'll tell you, I feel sorry for anyone who might have to live with you.
![]()
No I hate know-it-all douches, like yourself. Let's put it this way, African Americans, Caucasians and a person from Mexico all, GENERALLY, have their own look as well as other differences. Why they would not be considered their own "race" I don't know.
Do you see how in medical science, they are their own distinct category? Now STFU for once!!!
Abstract
Primary biliary cirrhosis (PBC) is an uncommon chronic cholestatic liver disease that primarily afflicts young and middle-aged Caucasian women; there are limited data on the clinical presentation and disease severity among non-Caucasian patients with this disease. The goal of this study was to examine differences in the severity of liver disease between Caucasian and non-Caucasian patients with PBC screened for enrollment in a large national multicenter clinical trial. Demographic features, symptoms, physical findings, and laboratory tests obtained during screening were examined in 535 patients with PBC with respect to ethnicity, gender, and antimitochondrial antibody (AMA) status; 73 of 535 (13.6%) were non-Caucasian (21 were African American, and 42 were Hispanic). Non-Caucasians were more likely than Caucasians to be ineligible for participation in the clinical trial (46.5% versus 25.1%, P = 0.0001), primarily because of greater disease severity. African Americans and Hispanics were also more likely to have a lower activity level, more severe pruritus, and more advanced disease. However, the mean age, male-to-female ratio, and seroprevalence of AMA positivity were similar between the 2 groups.